Montis Biosciences

Montis Biosciences

Biotechnology Research

Heverlee, Flemish Region 1,333 followers

Developing groundbreaking therapeutics that enhance the immune gatekeeping function of the perivascular microenvironment

About us

Our mission is to improve the lives of patients by developing groundbreaking therapeutics that enhance the immune gatekeeping function of the perivascular microenvironment. Our talented and dedicated team of scientists and professionals is continuously pushing the boundaries of scientific innovation, guided by our unwavering commitment to patients. We uphold the highest standards of quality and ethics and strive for excellence in every aspect of our work. We embrace change and challenge conventional thinking. Our diverse team, encompassing a wealth of backgrounds and perspectives, fosters a collaborative environment where individuals can thrive and be their authentic selves. Montis was founded based on the foundational science from the laboratories of Prof. Peter Carmeliet and Massimiliano Mazzone (VIB-KU Leuven), and is backed by an international syndicate of investors.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Heverlee, Flemish Region
Type
Privately Held
Founded
2020
Specialties
neuroinflammation, oncology, and neurodegeneration

Locations

Employees at Montis Biosciences

Updates

Similar pages

Funding